Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-24

Clinical Trial Update: Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating temozolomide with or without brain radiation therapy in patients with stage IV melanoma that has metastasized to the brain has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temozolomide (Temozolomide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 3 | Status: TERMINATED